{"id":"https://openalex.org/W4389008619","doi":"https://doi.org/10.1096/fasebj.30.1_supplement.926.3","title":"Abuse Liability and Anti\u2010Addiction Potential of the Atypical Mu Opioid Receptor Agonist IBNtxA","display_name":"Abuse Liability and Anti\u2010Addiction Potential of the Atypical Mu Opioid Receptor Agonist IBNtxA","publication_year":2016,"publication_date":"2016-04-01","ids":{"openalex":"https://openalex.org/W4389008619","doi":"https://doi.org/10.1096/fasebj.30.1_supplement.926.3"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.30.1_supplement.926.3","doi":"https://doi.org/10.1096/fasebj.30.1_supplement.926.3","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.30.1_supplement.926.3","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067184628","display_name":"Thomas M. Keck","orcid":"https://orcid.org/0000-0003-1845-9373","observed_orcids":["https://orcid.org/0000-0003-1845-9373"]},"institutions":[{"id":"https://openalex.org/I44265643","display_name":"Rowan University","ror":"https://ror.org/049v69k10","country_code":"US","type":"education","lineage":["https://openalex.org/I44265643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M Keck","raw_affiliation_strings":["Chemistry and Biochemistry, Rowan University, Glassboro, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry and Biochemistry, Rowan University, Glassboro, NJ","institution_ids":["https://openalex.org/I44265643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036707915","display_name":"Vincent Verchio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44265643","display_name":"Rowan University","ror":"https://ror.org/049v69k10","country_code":"US","type":"education","lineage":["https://openalex.org/I44265643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent Verchio","raw_affiliation_strings":["Chemistry and Biochemistry, Rowan University, Glassboro, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry and Biochemistry, Rowan University, Glassboro, NJ","institution_ids":["https://openalex.org/I44265643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031292318","display_name":"Chun Fu Wu","orcid":"https://orcid.org/0000-0002-0176-3873","observed_orcids":["https://orcid.org/0000-0002-0176-3873"]},"institutions":[{"id":"https://openalex.org/I44265643","display_name":"Rowan University","ror":"https://ror.org/049v69k10","country_code":"US","type":"education","lineage":["https://openalex.org/I44265643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chun Wu","raw_affiliation_strings":["Chemistry and Biochemistry, Rowan University, Glassboro, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry and Biochemistry, Rowan University, Glassboro, NJ","institution_ids":["https://openalex.org/I44265643"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023107129","display_name":"Gustavo Moura\u2010Letts","orcid":"https://orcid.org/0000-0001-8156-151X","observed_orcids":["https://orcid.org/0000-0001-8156-151X"]},"institutions":[{"id":"https://openalex.org/I44265643","display_name":"Rowan University","ror":"https://ror.org/049v69k10","country_code":"US","type":"education","lineage":["https://openalex.org/I44265643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gustavo Moura\u2010Letts","raw_affiliation_strings":["Chemistry and Biochemistry, Rowan University, Glassboro, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry and Biochemistry, Rowan University, Glassboro, NJ","institution_ids":["https://openalex.org/I44265643"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I44265643"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.25892478,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.4375,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.4375,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.3564000129699707,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.07639999687671661,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mu-opioid-receptor-agonists","display_name":"mu-opioid receptor agonists","score":0.8889999985694885},{"id":"https://openalex.org/keywords/opioid-abuse-liability","display_name":"opioid abuse liability","score":0.6499999761581421},{"id":"https://openalex.org/keywords/conditioned-place-preference","display_name":"conditioned place preference","score":0.9039999842643738},{"id":"https://openalex.org/keywords/reinstatement","display_name":"reinstatement","score":0.7699999809265137},{"id":"https://openalex.org/keywords/opioid-analgesia","display_name":"opioid analgesia","score":0.6000000238418579},{"id":"https://openalex.org/keywords/opioid-addiction-treatment","display_name":"opioid dependence treatment","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7319192886352539},{"id":"https://openalex.org/C35124327","wikidata":"https://www.wikidata.org/wiki/Q5159285","display_name":"Conditioned place preference","level":3,"score":0.7092359066009521},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.694835364818573},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6590253114700317},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5182657241821289},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.5052381157875061},{"id":"https://openalex.org/C14397066","wikidata":"https://www.wikidata.org/wiki/Q14911924","display_name":"\u03bc-opioid receptor","level":4,"score":0.501112699508667},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.48824456334114075},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.48263460397720337},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4699065089225769},{"id":"https://openalex.org/C2776319088","wikidata":"https://www.wikidata.org/wiki/Q12646464","display_name":"Rowan","level":2,"score":0.46722114086151123},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3804343342781067},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34787866473197937},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34728652238845825},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2957077622413635},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.24593952298164368},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15155470371246338},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12674063444137573},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.30.1_supplement.926.3","doi":"https://doi.org/10.1096/fasebj.30.1_supplement.926.3","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.30.1_supplement.926.3","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3046044599","https://openalex.org/W3048998485","https://openalex.org/W2965492419","https://openalex.org/W2081174576","https://openalex.org/W3176546523","https://openalex.org/W2063894455","https://openalex.org/W2564764545","https://openalex.org/W2774153857","https://openalex.org/W1474200642","https://openalex.org/W1902885317"],"abstract_inverted_index":{"OBJECTIVE":[0],"IBNtxA":[1,61,76,87,103,123,147,171],"is":[2,54,124],"a":[3,46,58],"novel":[4,168],"\u03bc":[5],"opioid":[6],"receptor":[7],"(MOR)":[8],"agonist,":[9],"structurally":[10],"related":[11],"to":[12,55,63,92,133],"the":[13,73,131,205],"classical":[14],"MOR":[15,23,135,180],"antagonist":[16],"naltrexone,":[17],"that":[18,129],"preferentially":[19],"signals":[20],"through":[21],"truncated":[22],"splice":[24,136,181],"variants.":[25],"This":[26],"unique":[27],"pharmacological":[28],"profile":[29],"produces":[30],"potent":[31],"analgesia":[32],"with":[33,139],"reduced":[34,144],"side":[35,145],"effects,":[36],"including":[37],"no":[38],"conditioned":[39],"place":[40],"preference":[41],"(CPP)":[42],"when":[43],"tested":[44,105],"at":[45,166],"single":[47],"dose.":[48],"The":[49],"purpose":[50],"of":[51,60,75,83,170,198,200],"this":[52],"study":[53],"1)":[56],"evaluate":[57],"range":[59],"doses":[62],"more":[64],"fully":[65],"assess":[66],"its":[67,107,114],"abuse":[68],"liability":[69],"and":[70,81,90,121,175,202,204,210],"2)":[71],"determine":[72],"effects":[74,108],"on":[77,113],"morphine":[78,84,93,100],"CPP":[79,96,101,111],"expression":[80,97],"reinstatement":[82,112],"CPP.":[85],"METHODS":[86],"was":[88,104],"synthesized":[89],"compared":[91],"in":[94,109,155],"standard":[95],"assays.":[98],"Following":[99],"training,":[102],"for":[106,172],"inducing":[110],"own":[115],"or":[116,187],"attenuating":[117],"morphine\u2010primed":[118],"reinstatement.":[119],"RESULTS":[120],"CONCLUSIONS":[122],"an":[125,152],"intriguing":[126],"preclinical":[127],"drug":[128],"opens":[130],"door":[132],"new":[134],"variant\u2010selective":[137],"pharmacotherapeutics":[138],"effective":[140],"analgesic":[141],"properties":[142],"but":[143],"effects.":[146],"may":[148],"have":[149],"utility":[150],"as":[151],"adjunct":[153],"therapy":[154],"agonist":[156],"replacement":[157],"strategies":[158],"(e.g.,":[159],"methadone).":[160],"Current":[161],"collaborative":[162],"efforts":[163],"are":[164],"aimed":[165],"developing":[167],"analogues":[169],"further":[173],"analysis":[174],"understanding":[176],"ligand\u2010receptor":[177],"interactions":[178],"across":[179],"variants":[182],"using":[183],"molecular":[184],"modeling.":[185],"Support":[186],"Funding":[188],"Information":[189],"Rowan":[190,206],"University":[191,207],"Seed":[192],"Fund;":[193],"travel":[194],"support":[195],"from":[196],"Dean":[197],"College":[199],"Science":[201],"Mathematics":[203],"Assistant":[208],"Professor":[209],"Instructor":[211],"Travel":[212],"Fund.":[213]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2023-11-27T00:00:00"}